Hydrogen-Rich Saline is Cerebroprotective in a Rat Model of Deep Hypothermic Circulatory Arrest
Transcript of Hydrogen-Rich Saline is Cerebroprotective in a Rat Model of Deep Hypothermic Circulatory Arrest
ORIGINAL PAPER
Hydrogen-Rich Saline is Cerebroprotective in a Rat Modelof Deep Hypothermic Circulatory Arrest
Li Shen • Jun Wang • Kun Liu • Chunzhang Wang •
Changtian Wang • Haiwei Wu • Qiang Sun •
Xuejun Sun • Hua Jing
Accepted: 11 April 2011 / Published online: 22 April 2011
� Springer Science+Business Media, LLC 2011
Abstract Deep hypothermic circulatory arrest (DHCA)
has been widely used in the operations involving the aortic
arch and brain aneurysm since 1950s; but prolonged
DHCA contributes significantly to neurological deficit
which remains a major cause of postoperative morbidity
and mortality. It has been reported that hydrogen exerts a
therapeutic antioxidant activity by selectively reducing
hydroxyl radical. In this study, DHCA treated rats devel-
oped a significant oxidative stress, inflammatory reaction
and apoptosis. The administration of HRS resulted in a
significant decrease in the brain injury, together with lower
production of IL-1b, TNF-a, 8-OHdG and MDA as well as
decreased activity of NOS while increased activity of SOD.
The apoptotic index as well as the expressions of caspase-3
in brain tissue was significantly decreased after treatment.
HRS administration significantly attenuated the severity of
DHCA induced brain injury by mechanisms involving
amelioration of oxidative stress, down-regulation of
inflammatory factors and reduction of apoptosis.
Keywords Cerebral protection � Deep hypothermic
circulatory arrest � Hydrogen � Oxidative stress � Rat
Abbreviation
DHCA Deep hypothermic circulatory arrest
8-OH-dG 8-Hydroxydeoxyguanosine
ELISA Enzyme-linked immunosorbent assay
EMSA Electromobility Shift Analysis
HRS Hydrogen-rich saline
IL-1b Interleukin-1bMDA Malondialdehyde
NF-jB Nuclear factor-jB
NOS Nitric oxide synthase
RNS Reactive nitrogen species
ROS Reactive oxygen species
SIRS Systemic inflammatory response syndrome
SOD Superoxide dismutase
TNF-a Tumor necrosis factor-a
Introduction
Deep hypothermia circulation arrest (DHCA) has been
used in the surgical repair of complex congenital heart
malformations and the operations involving the aortic arch
and brain aneurysm since invented in 1950s [1]. Such
technique has been widely used as it can provide a quiet,
dry and motionless surgical field for a perfect operation [2].
However, the long duration of DHCA results in some
severe neurological complications which contribute sub-
stantially to postoperative mortality and morbidity [3]. It is
reported that about 25% of patients undergoing a tempo-
rary exclusion of cerebral circulation suffer from tempo-
rary neurological dysfunction [4], and 55% of patients
undergoing DHCA demonstrated a neuropsychological
deficit 12 weeks after the operation [5]. How to limit the
neurological complications of DHCA is a critical issue that
must be solved practically. The pathophysiology of DHCA
L. Shen � J. Wang � K. Liu � C. Wang � C. Wang � H. Wu �H. Jing (&)
Department of Cardiothoracic Surgery, Jinling Hospital, Clinical
Medicine School of Nanjing University, 305 East Zhongshan
Road, Nanjing 210002, People’s Republic of China
e-mail: [email protected]
Q. Sun � X. Sun (&)
Department of Diving Medicine, Faculty of Naval Medicine,
Second Military Medical University, Shanghai 200433,
People’s Republic of China
e-mail: [email protected]
123
Neurochem Res (2011) 36:1501–1511
DOI 10.1007/s11064-011-0476-4
mainly consists of the systemic inflammatory response
syndrome (SIRS) caused by cardiopulmonary bypass and
the ischemia–reperfusion (I/R) injury associated with cir-
culatory arrest. It is believed that mechanisms of I/R-
induced damage are multifactorial and interdependent,
involving hypoxia, inflammatory responses and free radical
damage [6, 7]. The major free radicals causing severe tis-
sue damage include reactive oxygen species (ROS) and
reactive nitrogen species (RNS). Oxidative stress repre-
sents an imbalance between the production of free radicals
and the activity of antioxidant defense systems [8].
Therefore, in theory, agent with anti-inflammatory or anti-
oxidation activity may be cerebroprotective alleviating the
damage induced by DHCA.
Recently, Ohsawa et al. demonstrated that hydrogen
(H2) ameliorates focal ischemic injury in adult rats, the
mechanisms may be related to direct consumption of free
radical such as •OH by H2 [9]. It is also reported that H2
saturated water could attenuate superoxide formation in ex
vivo mouse brain slices with diminished endogenous free
radical buffering capacity [10]. Similar result has been
observed in chronically restrained mice [11] and the rat
model of carbon monoxide encephalopathy [12]. Addi-
tionally, Cai et al. found that H2 therapy after a mild
(90 min hypoxia) hypoxia–ischemia in neonatal rats
decreases infarction volume and apoptotic cell death of the
brain [13]. Further studies carried out in recent years also
indicated that H2 could effectively reduce the injury in the
experimental intestinal I/R model [14, 15, 16], myocardial
ischemia model [17, 18], contused spinal cord injury model
[19], chronic liver inflammation [20] and arteriosclerosis
patients [21].
Accumulated data suggested that the H2 could therapy
I/R lesions by mechanisms involving anti-inflammation
and anti-oxidation. However, the effects of H2 on brain
injury induced by DHCA have not yet been reported.
Prompted by the previous findings, we hypothesized that
the H2 was able to effectively ameliorate the brain injury
induced by DHCA by mechanisms involving anti-inflam-
mation and/or anti-oxidation. Our results provided evi-
dence that H2 is cerebroprotective in a rat model of DHCA.
Experimental Procedure
Animals and Protocol
This study was conformed to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institute of Health (NIH Publication No. 85–23, revised
1996) and was approved by the Animal Care and Use
Committee of Nanjing University. Male Sprague–Dawley
rats (250 ± 10 g) were housed with free access to food and
water in 12 h day/night cycle. All rats were acclimated for
7 days before any experimental procedures, and were fas-
ted for 12 h with water ad libitum before operation. Ani-
mals were randomly divided into the following three
groups: (1) Sham-operated group; (2) DHCA group; (3)
H2-treated DHCA group.
The hydrogen-rich saline (HRS) was prepared as
described by Cai et al. [22]. In brief, H2 was dissolved in
normal saline for 2 h under high pressure (0.4 MPa) to the
supersaturated level using a self-designed hydrogen-rich
water producing apparatus. The saturated H2 saline was
stored under atmospheric pressure at 4�C in an aluminum
bag without dead volume, sterilized by gamma radiation.
HRS was freshly prepared every week to ensure a constant
concentration more than 0.6 mM. Gas chromatography
(Biogas Analyzer Systems-1000, Mitleben, Japan) was
used to confirm the content of H2 in saline by the method
described by Ohsawa et al. [9].
The rats were anesthetized with 10% chloral hydrate
(0.4 ml/100 g body weight, i.p.), and the 4-vessel occlu-
sion (4-VO) rat global I/R model [23] was set up with some
modification [24]. Briefly, the anesthetized rat was incised
on the middle posterior neck, and the bilateral vertebral
arteries were dissected and electrocauterized carefully.
Subsequently, the rats were positioned supine, and the
bilateral common carotid arteries (CCA) were carefully
explored, isolated from the adjacent nerve tissue. Next,
bilateral CCA were snared loosely with a 7# thread, fol-
lowed by saturation of the incision. The rats were still in an
anesthetized state following these procedures. Subse-
quently, the rats were put in an ice nest with a thermometer
inserted into rectum about 5–6 cm-deep near sub-dia-
phragm to monitor the core temperature. The temperature
decreased slowly by no more than 3�C per 10 min. When
the core temperature reached 20�C, bilateral CCAs were
occluded for 45 min while the core temperature was
maintained between 20 ± 1�C. The normal saline (in
DHCA group) or HRS (in DHCA ? H2 group) were
intraperitoneally administered (5 ml/kg body weight)
10 min before the opening of bilateral CCAs. The rats were
then moved out if the ice nest and rewarmed to normal
body temperature at a rate less than 2�C per 10 min. After
rewarming, the rats were reared in the cage. We checked
blood flow signal of 4 vessels with the color Doppler
ultrasonography (Philips iE33, Sector array probe S12-4).
Rats with the vertebral artery blood flow signal were
excluded from the experiment. The sham-operated group
was only subjected to anesthesia and the procedures to
isolate four vessels without occlusion.
The rats were sacrificed 24 h after treatment for sample
collection. Blood was taken from the left ventricle, and the
separated serum was stored at -80�C immediately for
future assay. The rat brain was fast perfused with cold
1502 Neurochem Res (2011) 36:1501–1511
123
normal saline (4�C) through ascending aortic artery till the
backflow fluid in the right atrium was clear, then the brain
was removed quickly and stored at -80�C.
For histopathology analysis and TUNEL staining, the
rats were sacrificed 72 h after the treatment, and the brain
were perfused with 150 ml 4% paraformaldehyde/PB (PH
7.4) for 30 min after normal saline perfusion, followed by
immersion in the 4% paraformaldehyde/PB.
Histopathology Analysis
Brain tissues were sectioned (5 lm thick) and stained with
hematoxylin and eosin (HE) using standard methods. The
neuronal damage of the hippocampus CA1 region was eval-
uated qualitatively by an experienced pathologist blinded to
the identity of the samples with light microscopy. Normal
appearing neurons and neurons showing features of ischemic
cell death (shrunken cell bodies, triangulated, pyknotic
nuclei, and eosinophilic cytoplasm) were counted using a
defined rectangular field area with magnification 9200. Cell
death, expressed as neuropathological score, was assessed
using a 0–4 grading scale as described by Hua et al. (0: no
damage; 1:[0, B12.5% damage; 2:[12.5%, B25% damage;
3:[25%, B50% damage and 4:[50% damage) [25].
ELISA Assay
The brain tissues were homogenized on ice in 1 ml normal
saline (4�C) and centrifuged at 12,000 g at 4�C for 20 min.
The protein content in the brain was determined by Com-
massie blue assay. The levels of IL-1b, TNF-a and
8-OHdG in serum and brain were quantified using enzyme-
linked immunosorbent assay (ELISA) kits specific for rat
according to the manufacturers’ instructions (R&D sys-
tems). The concentrations of IL-10 were detected by
commercial ELISA kits (Biosource). The concentrations in
the brain samples were expressed as per milligram protein.
Colorimetric Assay
MDA concentration, nitric oxide synthase (NOS) and
superoxide dismutase (SOD) activity in the serum or brain
samples were measured using colorimetric kits according
to the manufacturers’ instructions (Nanjing Jiancheng
Institute of Bio-engineering, China).
TUNEL Staining for Apoptosis
The fixed brain samples were dehydrated and embedded in
paraffin, sectioned at 5 lm, and examined with TUNEL
staining according to the manufacturer’s instructions
(Roche). In brief, the sections were dewaxed and rehy-
drated by heating the slides at 60�C, followed by digestion
with proteinase K at 20 lg/ml for 15 min at room tem-
perature. The slides were rinsed three times with PBS and
then incubated in the TUNEL reaction mixture for 1 h at
37�C. Dried area around sample and added Converter-AP
on samples for 1 h at 37�C. After rinsing with PBS (5 min,
3 times), sections were colourated in dark with nitroblue
tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylpho-
sphate (BCIP). Six visual fields (0.6 mm2) of the CA1 area
of hippocampus were photographed in each section. The
number of stained cells in each field was counted (9400
magnification). One hundred cells were counted in each
field. The data were presented as the apoptosis index (AI).
Nuclear Protein Extract and EMSA for NF-jB
Nuclear protein was extracted and quantified as described
by Zhou ML, et al. [26]. Briefly, frozen brain samples were
homogenized in 0.8 ml ice-cold buffer A composed of
10 mmol/l HEPES pH 7.9, 10 mmol/l KCl, 2 mmol/l
MgCl2, 0.1 mmol/l EDTA, 1 mmol/l dithiothreitol (DTT),
and 0.5 mmol/l phenylmethylsulfonyl fluoride (PMSF) (all
from Sigma Chemical Co., St. Louis, Mo, USA). The
homogenates were incubated on ice for 30 min and vor-
texed for 30 s after addition of 50 ll 10% NP-40 (Sigma
Chemical Co., Mo, USA). The mixture was then centri-
fuged for 10 min (5,000 g, 4�C). The pellet was suspended
in 100 lL ice-cold buffer B composed of 50 mmol/l
HEPES pH 7.9, 50 mmol/l KCl, 300 mM NaCl, 0.1 mmol/
l EDTA, 1 mmol/l DTT, and 0.5 mmol/l PMSF, and 10%
(v/v) glycerol and incubated on ice 30 min with frequent
mixing. After centrifugation (12,000 g, 4�C) for 15 min,
the supernatants were collected as nuclear extracts and
stored at -70�C for further use. Protein concentration was
determined using a bicinchoninic acid assay kit with
bovine serum albumin as the standard (Pierce Biochemi-
cals, Rockford, Ill, USA).
EMSA was performed using a commercial kit (Gel Shift
Assay System; Promega, Madison, Wis, USA) following the
methods in our laboratory [26]. Consensus oligonucleotide
probe (5-AGTTGAGGGGACTTTCCCAGGC-3) was end-
labeled with [c-32P] ATP (Free Biotech., Beijing, China)
with T4-polynucleotide kinase. Nuclear protein (10 lg) was
preincubated in a total volume of 9 ll in a binding buffer,
consisting of 10 mmol/l Tris–HCl (pH 7.5), 4% glycerol,
1 mmol/lMgCl2, 0.5 mmol/l MEDTA, 0.5 mmol/l DTT,
0.5 mmol/l NaCl, and 0.05 g/l poly-(deoxyinosinicdeox-
ycytidylic acid) for 15 min at room temperature. Then 1 ll
32P-labled oligonucleotide probe was added, and also incu-
bated for 20 min at room temperature. Finally 1 ll gel
loading buffer was added to stop the reaction and the mixture
was subjected to nondenaturing 4% polyacrylamide gel
electrophoresis in 0.5 9 TBE buffer (Trisborate-EDTA).
After electrophoresis was conducted at 390 V for 1 h, the gel
Neurochem Res (2011) 36:1501–1511 1503
123
was vacuum-dried and exposed to X-ray film (Fuji Hyper-
film, Tokyo, Japan) at -70�C. Levels of NF-jB DNA binding
activity were quantified by computer-assisted densitometric
analysis.
Western Blotting to Determine Caspase-3 Activity
The tissue samples were homogenized in 10% (w/v) Radio-
Immunoprecipitation Assay buffer (50 mM Tris, pH 7.4,
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and
0.1% SDS) containing complete protease inhibitors (Sigma,
St. Louis, MO) and centrifuged at 16,000 g for 20 min. The
supernatants were collected and quantified for protein con-
centration by bicinchoninic acid assay method (Bio-Rad
Laboratories, Mississauga, Ontario, Canada). Prepared pro-
tein samples (375 lg/well) were separated on 8–16% SDS–
PAGE and transferred to a polyvinylidene fluoride mem-
brane (Millipore, Billerica, MA). The membranes were
blocked with 5% nonfat milk in 0.01 M PBS with 0.1%
Tween-20 (pH 7.4) at room temperature for 1 h. Then, the
membrane was incubated at 4�C overnight with cleaved
caspase-3 antibodies(Cell Signaling, Danvers, MA; 1:500,
diluted with 5% nonfat milk in 0.01 M PBS with 0.1%
Tween-20). After three washes in 0.01 M PBS with 0.1%
Tween-20, the membranes were incubated with horseradish
peroxidase-conjugated goat anti-rabbit (Santa Cruz Bio-
technology, Inc., Santa Cruz, CA) diluted to 1:2000 in PBS
with 0.1% Tween-20 for 1 h at room temperature. After three
washes in 0.01 M PBS with 0.1% Tween-20 again, the blots
were detected with Pierce ECL Western Blotting Substrate
(Thermo Fisher Scientific, Rockford, IL). To prove equal
loading, the blots were analyzed for b-actin expression using
an anti–b-actin antibody (Santa Cruz Biotechnology, Inc.).
Statistical Analysis
Data were expressed as means ± standard deviation(S.D.).
Statistical analysis was carried out with the SPSS Statistics
13.0 (SPSS Inc., Chicago, IL, USA) by using one-way
analysis of variance (ANOVA) to establish whether the
difference was statistically significant. A v2 test was per-
formed to analyze mortality. The level of significance was
set at P \ 0.05.
Results
Hydrogen-Rich Saline Administration Reduced
the Postoperative Mortality
We evaluated the mortality of the rats 24 h post-operation.
No death was observed in the sham group. In the DHCA
group, 7 rats died with a mortality of 35% (7/20). The HRS
administration improved the mortality of 15% (3/20).
Statistical analysis showed that there was a significant
difference in the mortality between DHCA group and
DHCA ? H2 group (v2 = 9.130, P = 0.010). HRS
administration significantly decreased mortality and
improved the general conditions in rats treated with
DHCA.
Hydrogen-Rich Saline Administration Improved
Pathological Features
The HE staining of the sham group showed that the
outline of pyramid cells in the CA1 area of hippocampus
was clear and the structure was compact. Big oval-shaped
cells with abundant cytoplasm were identified. The axons
were arranged with regular full nuclei, sparsely distrib-
uted nuclear chromatins and clear nucleoli. No neuronal
injury was observed. In contrast, substantial amount of
neuronal loss and a great number of dead cells were
observed in the DHCA group, the HE staining revealed
cells in CA1 sector arranged sparsely and the cell outline
was fuzzy. The eumorphism cells were significantly
reduced instead with the deflated cells and fuzzy-arranged
axons. Interestingly, HRS dramatically improved the
morphological changes found in rats treated with DHCA
which was confirmed by the HE staining (See Fig. 1). No
evidence was observed about the effects of HRS on the
pathological features in rats of sham group (data not
shown). The statistic analysis of neuopathological score to
hippocampal CA1 area showed there had a significant
differance between DHCA and DHCA ? H2 groups (see
Table 1).
Hydrogen-Rich Saline Administration Reduced
Oxidative Stress
Oxidative stress can cause toxic effects that damage all
components of a cell including lipids, proteins and DNA.
Malondialdehyde (MDA) is one of the major products
derived from lipid peroxidation and 8-Hydroxydeoxygu-
anosine (8-OH-dG) is considered to be a DNA-damage
biomarker. Our data showed that the rats subjected to
DHCA displayed a significant increased level of MDA and
8-OHdG as well as NOS activity both in serum and brain
tissue in contrast to the sham-operated rats. In accordance
with these results, DHCA treatment resulted in a decrease
in the SOD activity. Administration of HRS to the rats
treated with DHCA resulted in a marked reduction of the
NOS activity, MDA and 8-OHdG levels compared to the
DHCA group. Additionally, HRS significantly increased
the SOD activity in rats treated with DHCA. (See Fig. 2).
1504 Neurochem Res (2011) 36:1501–1511
123
Hydrogen-Rich Saline Administration Ameliorated
Inflammation Effectively
To evaluate inflammation level, we checked the concen-
trations of TNF-a and IL-1b in serum and brain as well as
brain water content. Significant elevation of these bio-
markers was observed in the DHCA group compared with
those in the sham group. HRS administration significantly
decreased the levels of TNF-a and IL-1b in serum and
brain as well as brain water content when compared with
those in DHCA group. In contrast, there were no differ-
ences in the levels of IL-10 in serum (590.83 ± 64.92 vs.
625.61 ± 88.3 P = 0.46 pg/ml, P = 0.36) or in brain tis-
sue (668.24 ± 62.77 vs. 684.11 ± 86.52 pg/g brain tissue,
P = 0.72) tested by ELISA between the DHCA and DHCA
? H2 groups. In addition, we assayed the NF-jB activity in
brain in three groups, and a similar reduction pattern was
obtained as that for TNF-a and IL-1b (See Fig. 3).
Hydrogen-Rich Saline Reduced Apoptosis
To evaluate the anti-apoptotic effects, caspase-3 activity in
brain tissue was assayed by western blotting. Moreover, we
checked the histopathology alteration with TUNEL stain-
ing in the CA1 area in the hippocampus that has been
shown to be the most ischemia-sensitive area in the brain.
[27]. Our TUNEL assay indicated that there were few
apoptotic cells in the sham group. However, the apoptotic
index in the DHCA group displayed markedly increased
compared with the sham group (P \ 0.01). In comparison
to the DHCA group, there were fewer TUNEL-positive
Fig. 1 Morphological features of CA1 area in rat’s hippocampus
from each group were evaluated by HE staining. (magnifications: a, b,c: 940; d, e, f: 9200; g, h, i:9400). In sham group (see a, d, g), the
outline of pyramid cells in CA1 area was clear and the structure was
compact (a, d). Cells were big with an intact oval shape and have
abundant cytoplasm. The axons were intact and lined up regular with
full nucleus, sparsely nuclear chromatins and clear nucleoli. No
necrosis cell was found (g). In DHCA group (see b, e, h), lots of
neuronal loss and dead cells were observed, the cells in CA1 sector
arranged sparsely and the cell outline was fuzzy (b, e). The
eumorphism cells were significantly reduced instead with the deflated
cells and the axons arranged fuzzy (h). In DHCA ? H2 group (see c, f,i) the morphological changes in rats were improved
Table 1 The neuopathological score of hippocampal CA1 area
Group n Neuopathological score
(mean ± S.D.)
DHCA group 10 2.3 ± 0.48
DHCA ? H2 group 10 1.2 ± 0.42�
The table shows the neuropathological score of hippocampal CA1
area in rat of DHCA group and DHCA ? H2 group. The score was
assessed by using a 0–4 grading scale (0: no damage; 1:[0, B12.5%
damage; 2:[12.5%, B25% damage; 3: [25%, B50% damage and 4:
[50% damage). There were 10 rats per group. (� P \ 0.01)
Neurochem Res (2011) 36:1501–1511 1505
123
cells and decreased apoptotic index in the DHCA rats
treated with HRS (P \ 0.01). HRS showed no effects of
numbers of TUNEL-positive cells in rats from sham group
(data not shown). The level of activated caspase-3 in the
DHCA group was significantly increased compared to the
sham group. The treatment of HRS significantly suppressed
the activation of caspase-3 in the DHCA ? H2 group which
was consistent with the results of TUNEL staining (See
Fig. 4).
Discussion
The present study demonstrated that HRS can attenuate the
severity of brain injury caused by DHCA by down-regu-
lating the expression of proinflammatory cytokines, as well
as reducing the apoptosis in the rat brain. Administration of
HRS remarkably improved the clinical symptoms 24 h
post-operation as measured by evaluating the general
condition and mortality. Histopathological assays further
Fig. 2 The levels of oxidative
stress in the serum and brain
tissues in rats from each group
(a, b, c, d serum, e, f, g, h brain
tissues). The rats subjected to
DHCA displayed a significant
increased the levels of MDA
and 8-OHdG as well as NOS
activity both in serum (b, c, d)
and brain tissues (f, g, h) when
compared with those in sham-
operated rats. In accordance to
these results, DHCA treatment
resulted in a decrease in SOD
activity (a, e). Administration of
hydrogen-rich saline resulted in
a marked reduction of the NOS
activity (b, f), MDA (c, g) and
8-OHdG (d, h) levels in rats
treated with DHCA compared to
those DHCA group.
Additionally, hydrogen-rich
saline significantly increased the
SOD activity (a, e) in rats
treated with DHCA. Data
represents mean ± S.D. (n = 10
per group). (*P \ 0.05,
**P \ 0.01, compared with
sham group; �P \ 0.05�P \ 0.01, compared with
DHCA group)
1506 Neurochem Res (2011) 36:1501–1511
123
supported the protective effects of HRS following brain
tissue injury in DHCA-treated rats. To our best knowl-
edge, this is the first study demonstrating that HRS has
potential cerebroprotective activity in a rat DHCA model
through mechanisms involving anti-oxidation and anti-
inflammation.
The pathophysiology of DHCA mainly consists of SIRS
caused by cardiopulmonary bypass and I/R injury as a
result of the circulatory arrest with the protection of
hypothermia. It was reported that the main pathophysiol-
ogy of I/R injury is the oxidative stress trigged by the
excessive production of free radicals [28]. NF-jB can be
activated by lesion-induced oxidative stress [29]. The
functional importance of NF-jB in inflammation is based
on its ability to regulate the promoters of multiple
inflammatory genes such as TNF-a, IL-1b, IL-6, and
ICAM-1 [30]. TNF-a is reported to be a major initiator of
inflammation and is released early after an inflammatory
stimulus [31] while IL-1b is regarded as the prototypic
‘‘multifunctional’’ cytokine and is induced in a multitude of
consequences of cell types [32]. The brain water content is
regarded as an index to quantify the magnitude of brain
edema 24 h after injury [33]. MDA is a commonly mea-
sured end point of free radical-induced lipid peroxidation,
and MDA concentration correlates with the extent of free
radical-induced damage [34]. 8-OHdG is formed from
deoxyguanosine in DNA by hydroxyl free radicals and
might serve as a sensitive biomarker of intracellular oxi-
dative stress in vivo [35]. SOD is one of the intracellular
enzymatic antioxidants that are responsible for disposing
Fig. 3 The inflammatory reaction in rat serum and brain tissue. (a, b,c, d is the concentrations of TNF-a, IL-1b in serum and brain tissues;
e is quantification of NF-jb DNA binding activity performed by
densitometric analysis; f is the brain water content; g is NF-jb DNA
binding activity by EMSA as shown by). The concentrations of TNF-
a (a, c), IL-1b (b, d) in serum, brain and brain water content (f)were all significantly elevated in DHCA rats when compared with
those in sham-operated group. Hydrogen-rich saline administration
significantly reduced the elevated levels of TNF-a (a, c), IL-1b (b, d)
in serum and brain as well as brain water content (f) when compared
with those in DHCA group. The bands were quantified using image
analysis software (Bandleader 3.0 software, Magnitec Ltd. Tel Aviv,
Israel). The relative intensity was determined by comparison with that
of the normal rat without any treatment. NF-jB activity in brain tissue
in DHCA group was also increased significantly compared to sham
group, while administration of hydrogen-rich saline decreased the
activity of NF-jB in DHCA treated rats (e). Data represents mean ±
S.D. (n = 6–10 per group). (*P \ 0.05, **P \ 0.01, compared with
sham group; �P \ 0.05 �P \ 0.01, compared with DHCA group)
Neurochem Res (2011) 36:1501–1511 1507
123
ROS such as H2O2 and O2••. Exposure to oxidants may
lead to enhanced expression of the enzyme NOS, resulting
in increased production of NO [36]. NOS is identified as a
source of ROS with special relevance to pathological
condition. NO has limited radical reactivity and combine
readily with O2••, and possibly H2O2, to produce the
highly oxidizing, non-radical compound, peroxynitrite
(ONOO•) [37]. Caspase 3 is considered to be the most
important subtype of the executioner caspases and is acti-
vated by any of the initiator caspases [38]. TUNEL staining
can easily differentiate apoptosis in the tissue by charac-
teristic apoptotic cells whose nucleus can be buffy col-
orated. In the present study, we found that DHCA
treatment caused significant oxidative stress as indicated by
the elevated levels of NOS, MDA and 8-OHdG but a
decreased level of SOD when compared to the sham group.
The rat model of DHCA also showed that both of the
inflammatory cytokines and cell apoptosis were signifi-
cantly increased compared with those in the sham group.
Recently, it was demonstrated that H2 is a novel anti-
oxidant with certain unique properties: (1) H2 could diffuse
freely within the body, without any side effects [20]. In other
words, H2 is permeable to cell membranes and can target
organelles, including nuclei and mitochondria, the latter
being the primary site of ROS generation and difficult
to target notoriously [39]. (2) H2 specially exclusively
Fig. 4 The evaluation of apoptosis in CA1 area in rat’s hippocampus
(a-i are the TUNEL staining, magnification: a, b, c: 940; d, e, f:9200; g, h, i: 9400; j is the caspase-3 activity in the rat brain; k is the
western blot image of cleaved caspase-3 in the rat brain, b-actin
provided as an inner control; l is the apoptotic index of TUNEL
staining.). Few apoptotic cells were observed in sham group (a, d, g).
However, the apoptotic index in DHCA group increased markedly
compared with those in sham group (P \ 0.01) (l). Compared with
those in DHCA group, there were less TUNEL-positive cells (c, f, i)
and decreased apoptotic index in DHCA rats (l) treated with
hydrogen-rich saline (P \ 0.01). The activity of caspase-3 in DHCA
group (j, k) was significantly increased compared to the sham group.
Treatment with hydrogen-rich saline significantly down-regulated the
activity of caspase-3 in DHCA ? H2 group (j, k) which was in
consistent with the results of TUNEL staining. Data represents mean
± S.D. (n = 6–10 per group). (*P \ 0.05, **P \ 0.01, compared
with sham group; �P \ 0.05 �P \ 0.01, compared with DHCA group)
1508 Neurochem Res (2011) 36:1501–1511
123
quenches detrimental ROS, such as •OH and ONOO•, while
maintaining the metabolic oxidation–reduction reaction and
other less potent ROS, such as O2••, H2O2, and nitric oxide
[9, 40]. (3) H2 is electronically neutral and is oxidized into
water in the body which is not harmful to cells.
Gharib et al. reported that the inhalation of H2 can
suppress the chronic hepatic inflammation in a rat model of
schistosomiasis-associated chronic liver inflammation [20].
Kajiya et al. reported that H2 released from intestinally
colonized bacteria can suppress inflammation in liver
induced by Concanavalin A. [41]. It is also reported that H2
could attenuate DSS-induced colitis by down-regulating
the expression of proinflammatory cytokines, as well as
suppressing the infiltration of macrophages in the colon
lesion. [42]. TNF-a and IL-1b, discharged from activated
macrophages and neutrophils, exert a considerable ampli-
fying effect on the systemic inflammatory response. Study
showed that the effect of oxidation and inflammatory
response (e.g., TNF-a, IL-1b) is mediated by NF-jB acti-
vation [43]. In the present study, HRS significantly
decreased the levels of TNF-a and IL-1b in serum and
brain tissues, suggesting that the protective effect of HRS
on brain was associated with down-regulation of TNF-aand IL-1b. In addition, we found that the NF-jB activity
was decreased by HRS, implying that the NF-jB activation
may be involved in the DHCA and the subsequent
pathology of brain injury. The administration of HRS could
dampen the inflammatory reaction effectively by reducing
the activity of NF-jB.
Apoptosis is programmed cell death which is character-
ized by specific ultrastructural changes that include cell
shrinkage, nuclear condensation and DNA fragmentation
[44]. Ischemia and hypoxia are linked to excessive neuronal
stimulation and hyperactivity, initiating a cascade of cel-
lular events leading to neuronal cell death [45, 46]. Apop-
tosis plays a crucial role in neuronal cell death after DHCA.
Damaged neurons are observed as early as 8 h after reper-
fusion and as long as 72 h later. [47]. Excessive ROS can
result in DNA fragmentation, lipid peroxidation, and inac-
tivation of protein [48] leading to apoptosis or necrosis
depending on the severity of oxidative stress. Among the
ROS, •OH and ONOO• are much more reactive and react
indiscriminately with nucleic acids, lipids and proteins.
Whereas H2 can quench the detrimental ROS •OH and
ONOO• specially and exclusively. At the molecular level,
apoptosis is activated by the aspartate-specific cysteine
protease cascade, and caspase-3 is considered to be one of
the most important executioner caspases and is activated by
any of the initiator caspases [38]. Our data indicated that,
TUNEL positive staining in the DHCA ? H2 group was
significantly decreased compared to those in the DHCA
group. Concomitantly, the caspase-3 activity in DHCA
rats treated by HRS was also down-regulated significantly
compared with the untreated DHCA rats, implying that
administration of HRS could effectively reduce apoptosis
caused by DHCA.
Conclusion
In summary, our results showed that HRS could effectively
protect the brain by means of anti-oxidation and anti-
inflammation in a rat model of DHCA. Our results suggested
that HRS treatment could ameliorate structural and func-
tional damages as a result of reduced oxidative stress that
can cause inflammation and apoptosis. Application of HRS
showed promising results in this model and may become a
powerful tool in the clinical treatment of brain injury caused
by DHCA. However, there still is a significant difference
between the sham and DHCA ? H2 group, which is similar
to the results reported by Matchett et al. [49] and Cai et al.
[13], those reports showed that brain injury induced by
DHCA exceeds the therapeutic potential of short-term
administration of HRS or the treatment is time-dependent on
the duration of the administration of HRS. As such, further
studies are still needed for clarification.
Acknowledgments This study was supported by grant from the
National Natural Science Foundation of China (No. 30972969). We
sincerely thank Dr. Geng-bao Feng and Miss Kang-li Hui for their
excellent technical assistance. We also sincerely thank Dr. Bing Guan
for his assistance with pathology analysis and Dr. Yi Li for language
editing.
Conflict of interest All authors declare that they have no conflict of
interest.
References
1. Ergin MA, O’Connor J, Guinto R, Griepp RB (1982) Experience
with profound hypothermia and circulatory arrest in the treatment
of aneurysms of the aortic arch Aortic arch replacement for acute
arch dissections. J Thorac Cardiovasc Surg 84:649–655
2. Niazi SA, Lewis FJ (1957) Profound hypothermia in the monkey
with recovery after long periods of cardiac standstill. J Appl
Physiol 10:137–138
3. Crawford ES, Svensson LG, Coselli JS, Safi HJ, Hess KR (1989)
Surgical treatment of aneurysm and/or dissection of the ascending
aorta, transverse aortic arch, and ascending aorta and transverse
aortic arch. Factors influencing survival in 717 patients. J Thorac
Cardiovasc Surg 98:659–673; discussion 673–654
4. Ergin MA, Uysal S, Reich DL, Apaydin A, Lansman SL,
McCullough JN, Griepp RB (1999) Temporary neurological
dysfunction after deep hypothermic circulatory arrest: a clinical
marker of long-term functional deficit. Ann Thorac Surg
67:1887–1890; discussion 1891–1884
5. Harrington DK, Bonser M, Moss A, Heafield MT, Riddoch MJ,
Bonser RS (2003) Neuropsychometric outcome following aortic
arch surgery: a prospective randomized trial of retrograde cere-
bral perfusion. J Thorac Cardiovasc Surg 126:638–644
Neurochem Res (2011) 36:1501–1511 1509
123
6. Parks DA, Granger DN (1988) Ischemia-reperfusion injury: a
radical view. Hepatology 8:680–682
7. Summers ST, Zinner MJ, Freischlag JA (1993) Production of
endothelium-derived relaxing factor (EDRF) is compromised
after ischemia and reperfusion. Am J Surg 166:216–220
8. Betteridge DJ (2000) What is oxidative stress? Metabolism
49:3–8
9. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K,
Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S (2007)
Hydrogen acts as a therapeutic antioxidant by selectively reduc-
ing cytotoxic oxygen radicals. Nat Med 13:688–694
10. Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, Handa S,
Takahashi R, Fukui M, Hasegawa G, Nakamura N, Fujinawa H,
Mori T, Ohta M, Obayashi H, Maruyama N, Ishigami A (2008)
Hydrogen-rich pure water prevents superoxide formation in brain
slices of vitamin C-depleted SMP30/GNL knockout mice. Bio-
chem Biophys Res Commun 375:346–350
11. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S
(2009) Consumption of molecular hydrogen prevents the stress-
induced impairments in hippocampus-dependent learning tasks
during chronic physical restraint in mice. Neuropsychopharma-
cology 34:501–508
12. Sun Q, Cai J, Zhou J, Tao H, Zhang JH, Zhang W, Sun XJ (2010)
Hydrogen-rich saline reduces delayed neurologic sequelae in
experimental carbon monoxide toxicity*. Crit Care Med
13. Cai J, Kang Z, Liu WW, Luo X, Qiang S, Zhang JH, Ohta S, Sun
X, Xu W, Tao H, Li R (2008) Hydrogen therapy reduces apop-
tosis in neonatal hypoxia-ischemia rat model. Neurosci Lett
441:167–172
14. Buchholz BM, Kaczorowski DJ, Sugimoto R, Yang R, Wang Y,
Billiar TR, McCurry KR, Bauer AJ, Nakao A (2008) Hydrogen
inhalation ameliorates oxidative stress in transplantation induced
intestinal graft injury. Am J Transplant 8:2015–2024
15. Zheng X, Mao Y, Cai J, Li Y, Liu W, Sun P, Zhang JH, Sun
X, Yuan H (2009) Hydrogen-rich saline protects against
intestinal ischemia/reperfusion injury in rats. Free Radic Res
43:478–484
16. Chen H, Sun YP, Hu PF, Liu WW, Xiang HG, Li Y, Yan RL, Su
N, Ruan CP, Sun XJ, Wang Q (2009) The effects of hydrogen-
rich saline on the contractile and structural changes of intestine
induced by ischemia-reperfusion in Rats. J Surg Res
17. Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K,
Kimura K, Endo J, Katayama T, Kawamura A, Kohsaka S,
Makino S, Ohta S, Ogawa S, Fukuda K (2008) Inhalation of
hydrogen gas reduces infarct size in the rat model of myocardial
ischemia-reperfusion injury. Biochem Biophys Res Commun
373:30–35
18. Sun Q, Kang Z, Cai J, Liu W, Liu Y, Zhang JH, Denoble PJ, Tao
H, Sun X (2009) Hydrogen-rich saline protects myocardium
against ischemia/reperfusion injury in rats. Exp Biol Med
(Maywood) 234:1212–1219
19. Chen C, Chen Q, Mao Y, Xu S, Xia C, Shi X, Zhang JH, Yuan H,
Sun X (2010) Hydrogen-rich saline protects against spinal cord
injury in rats. Neurochem Res 35:1111–1118
20. Gharib B, Hanna S, Abdallahi OM, Lepidi H, Gardette B, De
Reggi M (2001) Anti-inflammatory properties of molecular
hydrogen: investigation on parasite-induced liver inflammation.
C R Acad Sci III 324:719–724
21. Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S (2008)
Consumption of hydrogen water prevents atherosclerosis in
apolipoprotein E knockout mice. Biochem Biophys Res Commun
377:1195–1198
22. Cai J, Kang Z, Liu K, Liu W, Li R, Zhang JH, Luo X, Sun X
(2009) Neuroprotective effects of hydrogen saline in neonatal
hypoxia-ischemia rat model. Brain Res 1256:129–137
23. Pulsinelli WA, Brierley JB (1979) A new model of bilateral
hemispheric ischemia in the unanesthetized rat. Stroke
10:267–272
24. Milani H, Lepri ER, Giordani F, Favero-Filho LA (1999) Mag-
nesium chloride alone or in combination with diazepam fails to
prevent hippocampal damage following transient forebrain
ischemia. Braz J Med Biol Res 32:1285–1293
25. Hua F, Ma J, Li Y, Ha T, Xia Y, Kelley J, Williams DL, Browder
IW, Schweitzer JB, Li C (2006) The development of a novel
mouse model of transient global cerebral ischemia. Neurosci Lett
400:69–74
26. Zhou ML, Zhu L, Wang J, Hang CH, Shi JX (2007) The
inflammation in the gut after experimental subarachnoid hemor-
rhage. J Surg Res 137:103–108
27. Schmidt-Kastner R, Freund TF (1991) Selective vulnerability of
the hippocampus in brain ischemia. Neuroscience 40:599–636
28. Carden DL, Granger DN (2000) Pathophysiology of ischaemia-
reperfusion injury. J Pathol 190:255–266
29. Chen F, Castranova V, Shi X, Demers LM (1999) New
insights into the role of nuclear factor-kappaB, a ubiquitous
transcription factor in the initiation of diseases. Clin Chem
45:7–17
30. Hang CH, Chen G, Shi JX, Zhang X, Li JS (2006) Cortical
expression of nuclear factor kappaB after human brain contusion.
Brain Res 1109:14–21
31. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA Jr,
Cerami A, Shires GT, Lowry SF (1988) Cytokine appearance in
human endotoxemia and primate bacteremia. Surg Gynecol
Obstet 166:147–153
32. Church LD, Cook GP, McDermott MF (2008) Primer: inflam-
masomes and interleukin 1beta in inflammatory disorders. Nat
Clin Pract Rheumatol 4:34–42
33. Dogan A, Rao AM, Baskaya MK, Rao VL, Rastl J, Donaldson D,
Dempsey RJ (1997) Effects of ifenprodil, a polyamine site
NMDA receptor antagonist, on reperfusion injury after transient
focal cerebral ischemia. J Neurosurg 87:921–926
34. Kumar A, Mittal R, Khanna HD, Basu S (2008) Free radical
injury and blood-brain barrier permeability in hypoxic-ischemic
encephalopathy. Pediatrics 122:722–727
35. Kasai H (1997) Analysis of a form of oxidative DNA damage,
8-hydroxy-2’-deoxyguanosine, as a marker of cellular oxidative
stress during carcinogenesis. Mutat Res 387:147–163
36. Kaminsky DA, Mitchell J, Carroll N, James A, Soultanakis R,
Janssen Y (1999) Nitrotyrosine formation in the airways and lung
parenchyma of patients with asthma. J Allergy Clin Immunol
104:747–754
37. Beckman JS, Crapo JD (1997) The role of nitric oxide in limiting
gene transfer: parallels to viral host defenses. Am J Respir Cell
Mol Biol 16:495–496
38. Elmore S (2007) Apoptosis: a review of programmed cell death.
Toxicol Pathol 35:495–516
39. Maher P, Salgado KF, Zivin JA, Lapchak PA (2007) A novel
approach to screening for new neuroprotective compounds for the
treatment of stroke. Brain Res 1173:117–125
40. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S
(2007) Inhalation of hydrogen gas suppresses hepatic injury
caused by ischemia/reperfusion through reducing oxidative stress.
Biochem Biophys Res Commun 361:670–674
41. Kajiya M, Sato K, Silva MJ, Ouhara K, Do PM, Shanmugam KT,
Kawai T (2009) Hydrogen from intestinal bacteria is protective
for Concanavalin A-induced hepatitis. Biochem Biophys Res
Commun 386:316–321
42. Kajiya M, Silva MJ, Sato K, Ouhara K, Kawai T (2009) Hydrogen
mediates suppression of colon inflammation induced by dextran
sodium sulfate. Biochem Biophys Res Commun 386:11–15
1510 Neurochem Res (2011) 36:1501–1511
123
43. Karin M (1999) The beginning of the end: IkappaB kinase (IKK)
and NF-kappaB activation. J Biol Chem 274:27339–27342
44. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic bio-
logical phenomenon with wide-ranging implications in tissue
kinetics. Br J Cancer 26:239–257
45. Choi DW, Rothman SM (1990) The role of glutamate neuro-
toxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci
13:171–182
46. Olney JW, Ho OL, Rhee V, DeGubareff T (1973) Letter: neu-
rotoxic effects of glutamate. N Engl J Med 289:1374–1375
47. Ditsworth D, Priestley MA, Loepke AW, Ramamoorthy C,
McCann J, Staple L, Kurth CD (2003) Apoptotic neuronal death
following deep hypothermic circulatory arrest in piglets. Anes-
thesiology 98:1119–1127
48. Kuroda S, Siesjo BK (1997) Reperfusion damage following focal
ischemia: pathophysiology and therapeutic windows. Clin Neu-
rosci 4:199–212
49. Matchett GA, Fathali N, Hasegawa Y, Jadhav V, Ostrowski RP,
Martin RD, Dorotta IR, Sun X, Zhang JH (2009) Hydrogen gas is
ineffective in moderate and severe neonatal hypoxia-ischemia rat
models. Brain Res 1259:90–97
Neurochem Res (2011) 36:1501–1511 1511
123